Special issue: “Biology of skin pigmentation and pigmentary diseases”

Shosuke Ito,Zalfa Abdel‐Malek,Mauro Picardo

DOI: https://doi.org/10.1111/pcmr.12997

2021-07-01

Abstract:Pigment Cell & Melanoma Research, Volume 34, Issue 4, Page 705-706, July 2021.

dermatology,oncology,cell biology

What problem does this paper attempt to address?

Frontiers in pigment cell and melanoma research

Fabian V. Filipp,Stanca Birlea,Marcus W. Bosenberg,Douglas Brash,Pamela B. Cassidy,Suzie Chen,John A. D'Orazio,Mayumi Fujita,Boon‐Kee Goh,Meenhard Herlyn,Arup K. Indra,Lionel Larue,Sancy A. Leachman,Caroline Le Poole,Feng Liu‐Smith,Prashiela Manga,Lluis Montoliu,David A. Norris,Yiqun Shellman,Keiran S. M. Smalley,Richard A. Spritz,Richard A. Sturm,Susan M. Swetter,Tamara Terzian,Kazumasa Wakamatsu,Jeffrey S. Weber,Neil F. Box,Boon-Kee Goh,Feng Liu-Smith

DOI: https://doi.org/10.1111/pcmr.12728

2018-10-03

Abstract:In this perspective, we identify emerging frontiers in clinical and basic research of melanocyte biology and its associated biomedical disciplines. We describe challenges and opportunities in clinical and basic research of normal and diseased melanocytes that impact current approaches to research in melanoma and the dermatological sciences. We focus on four themes: (1) clinical melanoma research, (2) basic melanoma research, (3) clinical dermatology, and (4) basic pigment cell research, with the goal of outlining current highlights, challenges, and frontiers associated with pigmentation and melanocyte biology. Significantly, this document encapsulates important advances in melanocyte and melanoma research including emerging frontiers in melanoma immunotherapy, medical and surgical oncology, dermatology, vitiligo, albinism, genomics and systems biology, epidemiology, pigment biophysics and chemistry, and evolution.

dermatology,oncology,cell biology
Clinical and Biological Characterization of Skin Pigmentation Diversity and Its Consequences on UV Impact

Sandra Del Bino,Christine Duval,Françoise Bernerd

DOI: https://doi.org/10.3390/ijms19092668

IF: 5.6

2018-09-08

International Journal of Molecular Sciences

Abstract:Skin color diversity is the most variable and noticeable phenotypic trait in humans resulting from constitutive pigmentation variability. This paper will review the characterization of skin pigmentation diversity with a focus on the most recent data on the genetic basis of skin pigmentation, and the various methodologies for skin color assessment. Then, melanocyte activity and amount, type and distribution of melanins, which are the main drivers for skin pigmentation, are described. Paracrine regulators of melanocyte microenvironment are also discussed. Skin response to sun exposure is also highly dependent on color diversity. Thus, sensitivity to solar wavelengths is examined in terms of acute effects such as sunburn/erythema or induced-pigmentation but also long-term consequences such as skin cancers, photoageing and pigmentary disorders. More pronounced sun-sensitivity in lighter or darker skin types depending on the detrimental effects and involved wavelengths is reviewed.

biochemistry & molecular biology,chemistry, multidisciplinary
Clinicopathologic correlation of dermatologic diseases in patients with darker pigmentation

Sanjna Tripathy,Elizabeth Warbasse,Shira Ronen,Rami Al-Rohil,George F Cohen,Wei-Shen Chen,Anisha B Patel

DOI: https://doi.org/10.1093/ajcp/aqae013

2024-03-21

American Journal of Clinical Pathology

Abstract:Abstract Objectives Cutaneous diseases that disproportionately affect patients with darker pigmentation and their histologic features are historically understudied and undertreated. This review article aims to highlight the key clinical features, histopathology, and diagnostic pearls of several cutaneous diseases that commonly present in patients with darker pigmentation. Methods A literature search was conducted, and a list of cutaneous diseases that frequently affect patients with darker pigmentation was compiled. A group of experts expounded upon those that were most common or misdiagnosed according to scientific evidence and clinical practice. Results The diseases were divided into hypopigmented disorders, hyperpigmented disorders, scarring disorders, and alopecic disorders. Within each category, the etiology, clinical features, histopathology, and key histologic differential diagnoses are described and discussed. Conclusions As many clinicians are taught that there are no effective treatment options or that these diseases are considered “cosmetic” in nature, patients often do not get a thorough medical workup or skin biopsy. This article aims to decrease the knowledge gap and serve as a resource for anyone involved in the care of patients with these cutaneous conditions.

pathology
Special Issue "Materials for Photobiology"

Angela Scala,Enrico Caruso,Antonino Mazzaglia

DOI: https://doi.org/10.3390/ijms25063209

IF: 5.6

2024-03-12

International Journal of Molecular Sciences

Abstract:Photobiology is a challenging research area that aims to explore the interactions between light and living organisms and their biological consequences, with applications in the fields of photomedicine, photo(nano)technology, photosynthesis, and photosensory biology [...]

biochemistry & molecular biology,chemistry, multidisciplinary
Editor's Highlights — May 2024

Lajos Kemény

DOI: https://doi.org/10.1111/ijd.17170

2024-04-07

International Journal of Dermatology

Abstract:Dermatological research and education have predominantly focused on lighter skin types in the past, leading to a significant gap in knowledge and understanding of conditions in darker skin types. This has contributed to disparities in the diagnosis and treatment of diseases in patients with skin of color. In the current issue of the Journal, we highlight four papers on the epidemiology and clinics of skin of color patients but also emphasize the importance of education and research in the dermatopathology of SOC patients.

dermatology
A Focused review on the pathophysiology of post‐inflammatory hyperpigmentation

Jalal Maghfour,Jadesola Olayinka,Iltefat H. Hamzavi,Tasneem F. Mohammad

DOI: https://doi.org/10.1111/pcmr.13038

2022-03-31

Abstract:Pigment Cell & Melanoma Research, Accepted Article.

dermatology,oncology,cell biology
Special Issue, "Molecular Advances in Skin Diseases 2.0"

Naoko Kanda

DOI: https://doi.org/10.3390/ijms25115928

IF: 5.6

2024-05-30

International Journal of Molecular Sciences

Abstract:Recently, the pathomechanisms of various skin diseases have been progressively elucidated [...]

biochemistry & molecular biology,chemistry, multidisciplinary
Mechanisms underlying post-inflammatory hyperpigmentation: lessons from solar lentigo

G Cardinali,D Kovacs,M Picardo

DOI: https://doi.org/10.1016/S0151-9638(12)70127-8

Abstract:Hyperpigmentation of the skin is a common dermatologic condition in all skin types but most prominent in brown-skinned population. In skin of color any inflammation or injury can be accompanied by alterations in pigmentation (hyper/hypo-pigmentation). Postinflammatory hyperpigmentation (PIH) can be observed in many skin conditions including acne, eczema, and contact dermatitis. In the control of skin pigmentation, parallel to the cross-talk between keratinocytes and melanocytes, increasing evidence has underlined the crucial role exerted by the interactions between mesenchymal and epithelial cells through the release of fibroblast-derived growth factors. Among these factors, the keratinocyte growth factor (KGF), alone or in combination with interleukin-1α, induces melanin deposition in vitro and hyperpigmented lesions in vivo. Furthermore, a moderate increase of KGF and a high induction of its receptor have been shown in solar lentigo lesions, suggesting the involvement of this growth factor in the onset of the hyperpigmented spots. Several studies highlight the possible contribution of the fibroblast-derived melanogenic growth factors to the hyperpigmentated lesions, in the context of the mesenchymal - epithelial interactions modulating melanocyte functions.
[Mechanisms underlying post-inflammatory hyperpigmentation: lessons from solar lentigo]

G Cardinali,D Kovacs,M Picardo

DOI: https://doi.org/10.1016/S0151-9638(12)70118-7

Abstract:Hyperpigmentation of the skin is a common dermatologic condition in all skin types but most prominent in brown-skinned population. In skin of color any inflammation or injury can be accompanied by alterations in pigmentation (hyper/hypo-pigmentation). Postinflammatory hyperpigmentation (PIH) can be observed in many skin conditions including acne, eczema, and contact dermatitis. In the control of skin pigmentation, parallel to the cross-talk between keratinocytes and melanocytes, increasing evidence has underlined the crucial role exerted by the interactions between mesenchymal and epithelial cells through the release of fibroblast-derived growth factors. Among these factors, the keratinocyte growth factor (KGF), alone or in combination with interleukin-1α, induces melanin deposition in vitro and hyperpigmented lesions in vivo. Furthermore, a moderate increase of KGF and a high induction of its receptor have been shown in solar lentigo lesions, suggesting the involvement of this growth factor in the onset of the hyperpigmented spots. Several studies highlight the possible contribution of the fibroblast-derived melanogenic growth factors to the hyperpigmentated lesions, in the context of the mesenchymal - epithelial interactions modulating melanocyte functions.
Melanocyte biology and skin pigmentation

Jennifer Y. Lin,David E. Fisher

DOI: https://doi.org/10.1038/nature05660

IF: 64.8

2007-02-01

Nature

Abstract:Melanocytes are phenotypically prominent but histologically inconspicuous skin cells. They are responsible for the pigmentation of skin and hair, and thereby contribute to the appearance of skin and provide protection from damage by ultraviolet radiation. Pigmentation mutants in various species are highly informative about basic genetic and developmental pathways, and provide important clues to the processes of photoprotection, cancer predisposition and even human evolution. Skin is the most common site of cancer in humans. Continued understanding of melanocyte contributions to skin biology will hopefully provide new opportunities for the prevention and treatment of skin diseases.

multidisciplinary sciences
Diffuse Melanosis Cutis in the Era of Targeted Therapy

Fernanda Luiza Staub,Bruna Ossanai Schoenardie,Renan Rangel Bonamigo,Juliano Peruzzo

DOI: https://doi.org/10.5826/dpc.1401a20

2024-02-01

Dermatology Practical & Conceptual

Abstract:Accepted: November 7, 2023 ; Published: January 2024 Copyright: ©2024 Staub et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Juliano Peruzzo, Rua Ramiro Barcelos, 2350 - 90035-007 – Porto Alegre – RS, Brazil. Phone: +55 51 33598571 Email: julperuzzo@hcpa.edu.br Keywords : melanoma, target therapy, hyperpigmentation, metastatic melanoma, pdl-1 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. References 1. Minocha R, Kefford R, Uribe P, et al. Diffuse melanosis cutis in the setting of BRAF V600E mutant melanoma and treatment with targeted therapies: DMC treated with targeted therapies. Australas J Dermatol. 2015;56(2):128–30. 2. Sebaratnam DF, Venugopal SS, Frew JW, McMillan JR, et al. Diffuse melanosis cutis: A systematic review of the literature. J Am Acad Dermatol. Mar;68(3):482–8. 3. Piana S, Longo C. Diffuse Melanosis and Melanuria. N Engl J Med. 2019 21;380(12):1166–1166. 4. Chinai B, Piazza M, Patel R, Roy S. Diffuse melanosis cutis: a rare manifestation of metastatic melanoma. BMJ Case Rep. 2019 30;12(8):e230396. 5. Fields K, Milikowski C, Jewell T, Fields J. Localized diffuse melanosis associated with melanoma successfully treated with imiquimod cream 5%: a case report and review of the literature. Cutis. 2014;93(3):145–50. 6. Sebaratnam DF, Martin LK, Venugopal SS, Mangos G, et al. Diffuse melanosis cutis in the setting of BRAF(V600E) metastatic melanoma. Int J Dermatol. 2014;53(11):1409–11.

dermatology
The triennial International Pigment Cell Conference (IPCC)

Neil F. Box,Lionel Larue,Prashiela Manga,Lluis Montoliu,Richard A. Spritz,Fabian V. Filipp

DOI: https://doi.org/10.1186/s12967-018-1609-1

IF: 8.44

2018-10-03

Journal of Translational Medicine

Abstract:<h3 class="a-plus-plus">Abstract</h3> <p class="a-plus-plus">The International Federation of Pigment Cell Societies (IFPCS) held its XXIII triennial International Pigment Cell Conference (IPCC) in Denver, Colorado in August 2017. The goal of the summit was to provide a venue promoting a vibrant interchange among leading basic and clinical researchers working on leading-edge aspects of melanocyte biology and disease. The philosophy of the meeting, entitled Breakthroughs in Pigment Cell and Melanoma Research, was to deliver a comprehensive program in an inclusive environment fostering scientific exchange and building new academic bridges. This document provides an outlook on the history, accomplishments, and sustainability of the pigment cell and melanoma research community. Shared progress in the understanding of cellular homeostasis of pigment cells but also clinical successes and hurdles in the treatment of melanoma and dermatological disorders continue to drive future research activities. A sustainable direction of the societies creates an international forum identifying key areas of imminent needs in laboratory research and clinical care and ensures the future of this vibrant, diverse and unique research community at the same time. Important advances showcase wealth and breadth of the field in melanocyte and melanoma research and include emerging frontiers in melanoma immunotherapy, medical and surgical oncology, dermatology, vitiligo, albinism, genomics and systems biology, precision bench-to-bedside approaches, epidemiology, pigment biophysics and chemistry, and evolution. This report recapitulates highlights of the federate meeting agenda designed to advance clinical and basic research frontiers from melanoma and dermatological sciences followed by a historical perspective of the associated societies and conferences.</p>

medicine, research & experimental
Skin Hypopigmentation in Hematology Disorders

Roberto Mazzetto,Paola Miceli,Alvise Sernicola,Jacopo Tartaglia,Mauro Alaibac

DOI: https://doi.org/10.3390/hematolrep16020036

2024-06-04

Abstract:Hypopigmentation disorders pose significant diagnostic challenges in dermatology, sometimes reflecting underlying hematological conditions. This review explores the clinical presentations related to hypopigmentation in hematological disorders, focusing on vitiligo, morphea, and syndromic albinism. Vitiligo, an autoimmune disorder targeting melanocytes, involves interactions between genetic polymorphisms and immune responses, particularly regarding CD8+ T cells and IFN-γ. Drug-induced vitiligo, notably by immune checkpoint inhibitors and small-molecule targeted anticancer therapies, underscores the importance of immune dysregulation. Morphea, an inflammatory skin disorder, may signal hematological involvement, as seen in deep morphea and post-radiotherapy lesions. Syndromic albinism, linked to various genetic mutations affecting melanin production, often presents with hematologic abnormalities. Treatment approaches focus on targeting the immune pathways specific to the condition, and when that is not possible, managing symptoms. Understanding these dermatological manifestations is crucial for the timely diagnosis and management of hematological disorders.
Melanin distribution in corneocytes and fine patterns of pigmentation on pigmented areas in pigmentary disorders

Takeshi Sakamaki,Shoji Hayashi,Ritsuko Hayakawa

DOI: https://doi.org/10.1111/j.1600-0846.1999.tb00202.x

1999-02-01

Skin Research and Technology

Abstract:Hyperpigmentation on the face, such as chloasma, ephelides, and senile pigmentation, is a common problem in the dermatological field. It is desirable to obtain precise data on melanin distribution and hyperpigmentation patterns for correct diagnosis and suitable treatment; however, there are few reports of non‐invasive studies of hyperpigmentation of the face skin. In this study, we examined melanin distribution in corneocytes and fine patterns of pigmentation. Using adhesive tape, we stripped the skin on both pigmented areas and adjacent normal areas of the face. The melanin granules in the cells of the stripped specimens were stained by the Fontana‐Masson stain method. The melanin distribution of corneocytes was categorized into five types, and the frequency of each type was calculated. Pigmentation patterns were imaged by a videomicroscope equipped with a polarizer. The fine patterns of pigmentation were categorized into three basic patterns: reticulated, granulated and flat pigmentation. Melanin granules were concentrated around the nuclei in pigmented areas compared with normal areas. The frequency of each fine pattern was different in each pigmented disease. This study will be useful in assisting dermatologists in correcting clinical diagnoses of pigmented skin diseases.

dermatology
Melanin Biopolymers in Pharmacology and Medicine—Skin Pigmentation Disorders, Implications for Drug Action, Adverse Effects and Therapy

Marta Karkoszka,Jakub Rok,Dorota Wrześniok

DOI: https://doi.org/10.3390/ph17040521

IF: 4.6

2024-04-19

Pharmaceuticals

Abstract:Melanins are biopolymeric pigments formed by a multi-step oxidation process of tyrosine in highly specialized cells called melanocytes. Melanin pigments are mainly found in the skin, iris, hair follicles, and inner ear. The photoprotective properties of melanin biopolymers have been linked to their perinuclear localization to protect DNA, but their ability to scavenge metal ions and antioxidant properties has also been noted. Interactions between drugs and melanins are of clinical relevance. The formation of drug–melanin complexes can affect both the efficacy of pharmacotherapy and the occurrence of adverse effects such as phototoxic reactions and discoloration. Because the amount and type of melanin synthesized in the body is subject to multifactorial regulation—determined by both internal factors such as genetic predisposition, inflammation, and hormonal balance and external factors such as contact with allergens or exposure to UV radiation—different effects on the melanogenesis process can be observed. These factors can directly influence skin pigmentation disorders, resulting in hypopigmentation or hyperpigmentation of a genetic or acquired nature. In this review, we will present information on melanocyte biology, melanogenesis, and the multifactorial influence of melanin on pharmacological parameters during pharmacotherapy. In addition, the types of skin color disorders, with special emphasis on the process of their development, symptoms, and methods of treatment, are presented in this article.

pharmacology & pharmacy,chemistry, medicinal
Case Series with a Concise Review of the Current Literature

Carmen Cantisani,Giovanni Paolino,Antonio Di Guardo,Vito Gomes,Andrea Carugno,Maria Elisabetta Greco,Noah Musolff,Giulia Azzella,Giovanni Rossi,Giuseppe Soda,Caterina Longo,Giovanni Pellacani

DOI: https://doi.org/10.3390/jcm13030894

IF: 3.9

2024-02-04

Journal of Clinical Medicine

Abstract:Background: Agmination and/or satellitosis in pigmented blue lesions is a phenomenon rarely mentioned in the literature and not well known. This phenomenon can be expressed by several benign and malignant pigmented blue lesions, such as blue nevi, Spitz nevi, melanocytoma and melanoma. On this spectrum, dermoscopy, reflectance confocal microscopy (RCM) and dynamic Optical coherence tomography (D-OCT) represent non-invasive imaging technologies, which may help clinicians in the diagnosis of melanoma and non-melanoma skin cancers in daily clinical practice. Methods: Currently, in the literature there is a lack of new data about agminated blue lesions and blues lesions with satellitosis, as well as the lack of a recent and updated review of the literature about this topic. Therefore, considering that clinicians must be confident with the diagnosis of these rare skin lesions, we decided to carry out this work. Results: In this paper, four new cases of agminated pigmented cutaneous lesions were described. Moreover, a review of the current literature on this topic was performed. Conclusions: A clinical–pathological correlation is often needed to reach a correct diagnosis; currently, dermoscopy and non-invasive diagnostic techniques, such as reflectance confocal microscopy and optical coherence tomography, due to the depth of these skin lesions in the dermis, can only make a partial and limited contribution.

medicine, general & internal
Skin Phototype and Disease: A Comprehensive Genetic Approach to Pigmentary Traits Pleiotropy Using PRS in the GCAT Cohort

Xavier Farré,Natalia Blay,Beatriz Cortés,Anna Carreras,Susana Iraola-Guzmán,Rafael de de Cid

DOI: https://doi.org/10.3390/genes14010149

IF: 4.141

2023-01-06

Genes

Abstract:Human pigmentation has largely been associated with different disease prevalence among populations, but most of these studies are observational and inconclusive. Known to be genetically determined, pigmentary traits have largely been studied by Genome-Wide Association Study (GWAS), mostly in Caucasian ancestry cohorts from North Europe, identifying robustly, several loci involved in many of the pigmentary traits. Here, we conduct a detailed analysis by GWAS and Polygenic Risk Score (PRS) of 13 pigmentary-related traits in a South European cohort of Caucasian ancestry (n = 20,000). We observed fair phototype strongly associated with non-melanoma skin cancer and other dermatoses and confirmed by PRS-approach the shared genetic basis with skin and eye diseases, such as melanoma (OR = 0.95), non-melanoma skin cancer (OR = 0.93), basal cell carcinoma (OR = 0.97) and darker phototype with vitiligo (OR = 1.02), cataracts (OR = 1.04). Detailed genetic analyses revealed 37 risk loci associated with 10 out of 13 analyzed traits, and 16 genes significantly associated with at least two pigmentary traits. Some of them have been widely reported, such as MC1R, HERC2, OCA2, TYR, TYRP1, SLC45A2, and some novel candidate genes C1QTNF3, LINC02876, and C1QTNF3-AMACR have not been reported in the GWAS Catalog, with regulatory potential. These results highlight the importance of the assess phototype as a genetic proxy of skin functionality and disease when evaluating open mixed populations.

genetics & heredity
Melanocyte Colonization and Pigmentation of Breast Carcinoma: Description of Two Pathological Cases and Review of Literature

Angela Santoro,Giuseppe Angelico,Vincenzo Fiorentino,Qianqian Zhang,Saveria Spadola,Angela Carlino,Alejandro Martin Sanchez,Gianluca Franceschini,Gian Franco Zannoni,Antonino Mulè

DOI: https://doi.org/10.3390/diagnostics11040709

IF: 3.6

2021-04-15

Diagnostics

Abstract:Colonization of breast carcinoma by non-neoplastic melanocytes of epidermal origin was first described by Azzopardi and Eusebi in 1977. We herein report two cases on the exceptional clinical and pathological features of this phenomenon in a 66-year-old and a 51-year-old patients. The pathogenesis is not fully understood, but a disrupted basement membrane and the role of tumoral growth factors are considered essential.

medicine, general & internal
Atypical Dyschromia in Skin of Color

Mohammed Moumen,Amy J McMichael,Amy J. McMichael

DOI: https://doi.org/10.36849/jdd.7683

2024-01-01

Journal of Drugs in Dermatology

Abstract:Dyschromia is a concern for many patients, especially persons of color. Postinflammatory hypopigmentation and depigmentation can affect all skin types; however, it is more apparent in those with darker skin. Some members of the dermatology community may not comprehensively understand the mechanisms of these reactions and the extent of the psychosocial effect they have on persons of color. Skin of color patients experiencing a decrease or loss of pigmentation are left with few treatment options, with no available evidence-based treatment established from a sufficient sample size. Several diseases may present with hypopigmentation and/or depigmentation despite this not being a major criterion for these conditions, including atopic dermatitis, lichen planus, discoid lupus erythematosus, polymorphous light eruption, and scleroderma. Here, we present three cases of atypical dyschromia in skin of color to highlight the underlying hypo- and depigmentation that may present with active disease and persist despite appropriate treatment. Practice Points: 1. These cases foreground the potential for a range of dermatologic conditions to result in atypical pigment changes in persons of color. 2. Postinflammatory hypopigmentation or depigmentation may persist in skin of color despite the regression of active disease.J Drugs Dermatol. 2024;23(2):100-102. doi:10.36849/JDD.7683.

dermatology
Facial Hyperpigmentation in Skin of Color: Special Considerations and Treatment

Neelam A. Vashi,Stephen A. Wirya,Meyene Inyang,Roopal V. Kundu

DOI: https://doi.org/10.1007/s40257-016-0239-8

2016-12-09

American Journal of Clinical Dermatology

Abstract:Differences in cutaneous diseases in people of color call for nuanced evaluation and management. One of the most common dermatological complaints from patients with skin of color is dyspigmentation, particularly hyperpigmentation. The challenge for clinicians is to establish correct diagnoses along with consistently successful treatments to meet the needs of the increasingly diverse population served. This review focuses on facial hyperpigmentation and outlines the most common skin disorders and treatment options.

dermatology

Special issue: “Biology of skin pigmentation and pigmentary diseases”

Frontiers in pigment cell and melanoma research

Clinical and Biological Characterization of Skin Pigmentation Diversity and Its Consequences on UV Impact

Clinicopathologic correlation of dermatologic diseases in patients with darker pigmentation

Special Issue "Materials for Photobiology"

Editor's Highlights — May 2024

A Focused review on the pathophysiology of post‐inflammatory hyperpigmentation

Special Issue, "Molecular Advances in Skin Diseases 2.0"

Mechanisms underlying post-inflammatory hyperpigmentation: lessons from solar lentigo

[Mechanisms underlying post-inflammatory hyperpigmentation: lessons from solar lentigo]

Melanocyte biology and skin pigmentation

Diffuse Melanosis Cutis in the Era of Targeted Therapy

The triennial International Pigment Cell Conference (IPCC)

Skin Hypopigmentation in Hematology Disorders

Melanin distribution in corneocytes and fine patterns of pigmentation on pigmented areas in pigmentary disorders

Melanin Biopolymers in Pharmacology and Medicine—Skin Pigmentation Disorders, Implications for Drug Action, Adverse Effects and Therapy

Case Series with a Concise Review of the Current Literature

Skin Phototype and Disease: A Comprehensive Genetic Approach to Pigmentary Traits Pleiotropy Using PRS in the GCAT Cohort

Melanocyte Colonization and Pigmentation of Breast Carcinoma: Description of Two Pathological Cases and Review of Literature

Atypical Dyschromia in Skin of Color

Facial Hyperpigmentation in Skin of Color: Special Considerations and Treatment